Variable therapeutic effectiveness of clopidogrel in acute coronary syndromes
- 1 March 2006
- journal article
- editorial
- Published by Elsevier in Journal of Thrombosis and Haemostasis
- Vol. 4 (3) , 539-541
- https://doi.org/10.1111/j.1538-7836.2005.01777.x
Abstract
No abstract availableThis publication has 30 references indexed in Scilit:
- Evidence that pre‐existent variability in platelet response to ADP accounts for ‘clopidogrel resistance’Journal of Thrombosis and Haemostasis, 2007
- Absorption, Metabolization, and Antiplatelet Effects of 300-, 600-, and 900-mg Loading Doses of ClopidogrelCirculation, 2005
- Clopidogrel Effect on Platelet REactivity in Patients With Stent ThrombosisJournal of the American College of Cardiology, 2005
- Variability in platelet responsiveness to clopidogrel among 544 individualsJournal of the American College of Cardiology, 2005
- Clopidogrel resistanceCatheterization and Cardiovascular Interventions, 2004
- Clopidogrel Resistance Is Associated With Increased Risk of Recurrent Atherothrombotic Events in Patients With Acute Myocardial InfarctionCirculation, 2004
- Does the use of statins compromise the effectiveness of platelet inhibition by clopidogrel?Platelets, 2004
- Failure of clopidogrel to reduce platelet reactivity and activation following standard dosing in elective stenting: implications for thrombotic events and restenosisPlatelets, 2004
- Pharmacokinetics of clopidogrel after administration of a high loading doseThrombosis and Haemostasis, 2004
- Clopidogrel for Coronary StentingCirculation, 2003